|
|
500 Forbes Blvd.
South San Francisco, CA 94080 USA
phone:(650) 266-3000
fax:(650) 266-3010 |
| Symbol |
CEGE |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.cellgenesys.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Human disease therapies based on gene modification. |
|
| Management |
|
|
|
|
|
| Keywords |
| human disease therapies, gene modification, cancer vaccines, oncolytic virus |
|
|
|
|
| Description |
|
Cell Genesys, Inc. focuses its research and product development efforts on human disease therapies that are based on gene modification technologies. The Company aims to develop and commercialize biological therapies, including cancer vaccines, oncolytic virus therapies and cancer gene therapies, to treat multiple types of cancer. |
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
